Cargando…

Presentation, management, and outcomes of complications following prostate cancer therapy

OBJECTIVE: To characterize complications of prostate cancer therapy and operative management in patients referred to our institution for surgical intervention. MATERIALS AND METHODS: Data was abstracted from a retrospectively collected single surgeon database at a large tertiary care referral-based...

Descripción completa

Detalles Bibliográficos
Autores principales: Zaid, Uwais B., McAninch, Jack W., Glass, Allison S., Cinman, Nadya M., Breyer, Benjamin N.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: AME Publishing Company 2014
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4708165/
https://www.ncbi.nlm.nih.gov/pubmed/26816763
http://dx.doi.org/10.3978/j.issn.2223-4683.2014.04.05
_version_ 1782409413300060160
author Zaid, Uwais B.
McAninch, Jack W.
Glass, Allison S.
Cinman, Nadya M.
Breyer, Benjamin N.
author_facet Zaid, Uwais B.
McAninch, Jack W.
Glass, Allison S.
Cinman, Nadya M.
Breyer, Benjamin N.
author_sort Zaid, Uwais B.
collection PubMed
description OBJECTIVE: To characterize complications of prostate cancer therapy and operative management in patients referred to our institution for surgical intervention. MATERIALS AND METHODS: Data was abstracted from a retrospectively collected single surgeon database at a large tertiary care referral-based medical center. Variables included age, prostate cancer therapy, complication(s) and their management, and number of operations. Descriptive statistics were used. RESULTS: From 2006-2010, 890 patients underwent genitourinary surgery, of which 139 were to treat complications arising from prostate cancer therapy. Complications stemmed from radical prostatectomy (RP) monotherapy, RP and external beam radiation therapy (EBRT) or brachytherapy (BT), EBRT only, BT only, and combination EBRT and BT. Complications included urinary incontinence (UI), urethral strictures, bladder neck contractures, and fistulas. UI and bladder neck contractures were more common in patients treated with RP or RP with EBRT or BT. Strictures and fistulas were common in patients treated with EBRT or BT. Interventions included direct vision internal urethrotomy, artificial urinary sphincter, urethral reconstruction, UroLume urethral stent, urethral sling, repair of fistulas, and balloon dilation. Forty eight percent of patients required multiple operations. The median number of interventions was two. CONCLUSIONS: We operatively managed patients treated with non-surgical and surgical modalities for prostate cancer. Complications included UI, fistulas, strictures, and bladder neck contractures. These were managed with a variety of operative interventions. As more men undergo treatment for localized disease, more will inevitably have complications stemming from interventions.
format Online
Article
Text
id pubmed-4708165
institution National Center for Biotechnology Information
language English
publishDate 2014
publisher AME Publishing Company
record_format MEDLINE/PubMed
spelling pubmed-47081652016-01-26 Presentation, management, and outcomes of complications following prostate cancer therapy Zaid, Uwais B. McAninch, Jack W. Glass, Allison S. Cinman, Nadya M. Breyer, Benjamin N. Transl Androl Urol Original Article OBJECTIVE: To characterize complications of prostate cancer therapy and operative management in patients referred to our institution for surgical intervention. MATERIALS AND METHODS: Data was abstracted from a retrospectively collected single surgeon database at a large tertiary care referral-based medical center. Variables included age, prostate cancer therapy, complication(s) and their management, and number of operations. Descriptive statistics were used. RESULTS: From 2006-2010, 890 patients underwent genitourinary surgery, of which 139 were to treat complications arising from prostate cancer therapy. Complications stemmed from radical prostatectomy (RP) monotherapy, RP and external beam radiation therapy (EBRT) or brachytherapy (BT), EBRT only, BT only, and combination EBRT and BT. Complications included urinary incontinence (UI), urethral strictures, bladder neck contractures, and fistulas. UI and bladder neck contractures were more common in patients treated with RP or RP with EBRT or BT. Strictures and fistulas were common in patients treated with EBRT or BT. Interventions included direct vision internal urethrotomy, artificial urinary sphincter, urethral reconstruction, UroLume urethral stent, urethral sling, repair of fistulas, and balloon dilation. Forty eight percent of patients required multiple operations. The median number of interventions was two. CONCLUSIONS: We operatively managed patients treated with non-surgical and surgical modalities for prostate cancer. Complications included UI, fistulas, strictures, and bladder neck contractures. These were managed with a variety of operative interventions. As more men undergo treatment for localized disease, more will inevitably have complications stemming from interventions. AME Publishing Company 2014-06 /pmc/articles/PMC4708165/ /pubmed/26816763 http://dx.doi.org/10.3978/j.issn.2223-4683.2014.04.05 Text en 2014 Translational Andrology and Urology. All rights reserved.
spellingShingle Original Article
Zaid, Uwais B.
McAninch, Jack W.
Glass, Allison S.
Cinman, Nadya M.
Breyer, Benjamin N.
Presentation, management, and outcomes of complications following prostate cancer therapy
title Presentation, management, and outcomes of complications following prostate cancer therapy
title_full Presentation, management, and outcomes of complications following prostate cancer therapy
title_fullStr Presentation, management, and outcomes of complications following prostate cancer therapy
title_full_unstemmed Presentation, management, and outcomes of complications following prostate cancer therapy
title_short Presentation, management, and outcomes of complications following prostate cancer therapy
title_sort presentation, management, and outcomes of complications following prostate cancer therapy
topic Original Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4708165/
https://www.ncbi.nlm.nih.gov/pubmed/26816763
http://dx.doi.org/10.3978/j.issn.2223-4683.2014.04.05
work_keys_str_mv AT zaiduwaisb presentationmanagementandoutcomesofcomplicationsfollowingprostatecancertherapy
AT mcaninchjackw presentationmanagementandoutcomesofcomplicationsfollowingprostatecancertherapy
AT glassallisons presentationmanagementandoutcomesofcomplicationsfollowingprostatecancertherapy
AT cinmannadyam presentationmanagementandoutcomesofcomplicationsfollowingprostatecancertherapy
AT breyerbenjaminn presentationmanagementandoutcomesofcomplicationsfollowingprostatecancertherapy